2025 annual financial data
MaxCyte, Inc. 2025 Net margin
MaxCyte, Inc. 2025 net margin with verified reported values.
Direct answer
Net margin was -135.14%.
Operating income was -45,285,000 USD and net income was -44,630,000 USD.
Operating cash flow was -34,410,000 USD.
Get free MaxCyte, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 33,026,000 USD
- Operating income
- -45,285,000 USD
- Net income
- -44,630,000 USD
- Operating cash flow
- -34,410,000 USD